Influenza A Nucleoprotein Mouse mAb (IVD抗体) | Bioss

货号:V22719
产品详情
相关标记
相关产品
相关文献
常见问题

概述

产品编号
V22719
英文名称
Influenza A Nucleoprotein Mouse mAb
中文名称
甲型流感病毒核蛋白单克隆抗体
英文别名
Common flu NP; Influenza A virus NP; NP; Nucleocapsid protein; Nucleoprotein; Protein N; Seasonal Influenza A (H1N1) Nucleocapsid Protein
抗体来源
Mouse
免疫原
Recombinant Influenza A Nucleoprotein: 1-498/498
亚型
IgM
性状
Liquid
纯化方法
affinity purified by Protein A
克隆类型
Monoclonal
克隆号
2F3
理论分子量
56 kDa
储存液
0.01M PBS(pH7.4)
SWISS
纯度
>90% as determined by SDS-PAGE
保存条件
Shipped at 2-8℃.
注意事项
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍
A型流感病毒H5N1-M2型流感病毒与很多流感病毒型同源,其同源性很高:H7N7 H9N2 H13N6 H16N3 H1N1 N2N1 H3N2 H2N2 等等并仍在不断的变异。
背景资料
Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.
Influenza A Virus [A/California/04/2009(H1N1)]

产品应用

产品应用: ELISA, ICA

交叉反应

交叉反应: Influenza A Nucleoprotein [A/Victoria/4897/2022 (H1N1)], Influenza A Nucleoprotein [A/Wisconsin/67/2022(H1N1)], Influenza A Nucleoprotein [A/Victoria/2570/2019(H1N1)], Influenza A Nucleoprotein [A/Wisconsin/588/2019(H1N1)], Influenza A Nucleoprotein [A/Darwin/9/2021(H3N2)], Influenza A Nucleoprotein [A/Darwin/6/2021(H3N2)], Influenza A Nucleoprotein [A/Massachusetts/18/2022(H3N2)], Influenza A Nucleoprotein [A/Thailand/1(KAN-1)/2004 (H5N1)], Influenza A Nucleoprotein [A/Hong_Kong/483/1997(H5N1)]

相关产品

暂无相关产品

靶标

基因名
PB2
蛋白名
Polymerase basic protein 2
亚基
Oligomer. Interacts with human SLC25A6/ANT3 and VDAC1 (By similarity).
亚细胞定位
Host mitochondrion inner membrane. Host nucleus. Host cytoplasm, host cytosol. Note=Inner mitochondrial membrane in most cells types. Otherwise is detected in the nucleus and cytosol (By similarity).
翻译后修饰
N-glycosylated.
相似性
Belongs to the influenza viruses PB1-F2 family.
功能
Plays an important role in promoting lung pathology in both primary viral infection and secondary bacterial infection. Promotes alteration of mitochondrial morphology, dissipation of mitochondrial membrane potential, and cell death. Alternatively, inhibits the production of interferon in the infected cell at the level of host mitochondrial antiviral signaling MAVS. Its level of expression differs greatly depending on which cell type is infected, in a manner that is independent of the levels of expression of other viral proteins. Monocytic cells are more affected than epithelial cells. Seems to disable virus-infected monocytes or other host innate immune cells. May also act in trans: extracellular PB1-F2 released by infected cells could potentially inactivate hosts cell recruitment to the site of infection. During early stage of infection, may predispose the mitochondria to permeability transition through interaction with human SLC25A6/ANT3 and VDAC1. These proteins participate in the formation of the permeability transition pore complex (PTPC) responsible of the release of mitochondrial products that triggers apoptosis (By similarity).

同靶标产品

相关文献

常见问题